CIK 0000315545
- Non-accelerated filer
- Smaller reporting company
PROVECTUS BIOPHARMACEUTICALS, INC.
Sign in to watch- Ticker
- PVCT
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900031917
- Phone
- +1 866-594-5999
- Business address
- 800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
- Former names
- PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 53 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-09-07 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Stock Options (Right to Buy) | −100,000 | 900,000 | ||
| 2011-09-06 | WACHTER ERIC PHD Vice President Pharmaceuticals | Grant or award · Stock Options (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2011-09-06 | SCOTT TIMOTHY PHD President | Grant or award · Stock Options (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2011-09-06 | DEES H CRAIG Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2011-09-06 | CULPEPPER PETER R Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2011-07-29 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion | +100,000 | $1.00 | $100K | 4,226,570 |
| 2011-07-29 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Stock Options (Right to Buy) | −100,000 | 0 | ||
| 2011-07-12 | Smith Alfred E. IV Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2011-07-06 | WACHTER ERIC PHD Vice President Pharmaceuticals | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2011-07-06 | SCOTT TIMOTHY PHD President | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2011-07-06 | McMasters Kelly M Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2011-07-06 | FUCHS STUART Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2011-07-06 | DEES H CRAIG Chief Executive Officer | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2011-05-03 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion | +100,000 | $1.00 | $100K | 4,126,570 |
| 2011-05-03 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Stock Options (Right to Buy) | −100,000 | 100,000 | ||
| 2011-05-03 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion | +133,333 | $0.75 | $100K | 677,042 |
| 2011-05-03 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion · Stock Options (Right to Buy) | −133,333 | 33,334 | ||
| 2011-04-20 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion | +100,000 | $1.00 | $100K | 4,026,570 |
| 2011-04-20 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Stock Options (Right to Buy) | −100,000 | 200,000 | ||
| 2011-04-12 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion | +150,000 | $1.00 | $150K | 3,926,570 |
Page 19 of 28 · 553 trades